Re: #ESCCongress 2019 round-up
|
2
|
Resverlogix Corp.
|
Sep 09, 2019 04:09PM
|
Re: TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 27, 2019 03:00PM
|
Re: TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 27, 2019 02:27PM
|
Re: High Finance
|
3
|
Resverlogix Corp.
|
Aug 25, 2019 02:41PM
|
Re: TLD Confidence
|
5
|
Resverlogix Corp.
|
Aug 25, 2019 02:34PM
|
Re: High Finance
|
7
|
Resverlogix Corp.
|
Aug 24, 2019 01:14PM
|
Re: Publication / Resverlogix An Author
|
3
|
Resverlogix Corp.
|
Aug 21, 2019 09:14AM
|
Re: A birthday present for DM?
|
1
|
Resverlogix Corp.
|
Aug 21, 2019 08:56AM
|
Re: New PP on Aug 13
|
2
|
Zenith Epigenetics
|
Aug 21, 2019 07:40AM
|
Re: Anyone else find it odd......
|
4
|
Resverlogix Corp.
|
Aug 19, 2019 04:56PM
|
Immunotherapy for Cancer
|
3
|
Zenith Epigenetics
|
Aug 16, 2019 04:32PM
|
Re: BETonMACE and Aminotransferases
|
4
|
Resverlogix Corp.
|
Aug 14, 2019 01:15PM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
6
|
Zenith Epigenetics
|
Aug 09, 2019 01:37PM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 08, 2019 03:21PM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 07, 2019 11:20AM
|
Re: Liquidity
|
2
|
Zenith Epigenetics
|
Aug 03, 2019 02:56PM
|
Re: Liquidity
|
3
|
Zenith Epigenetics
|
Aug 03, 2019 02:55PM
|
Re: Liquidity
|
2
|
Zenith Epigenetics
|
Aug 02, 2019 02:59PM
|
Liquidity
|
3
|
Zenith Epigenetics
|
Aug 01, 2019 02:15PM
|
Re: Sedar filings - Loan balance
|
3
|
Resverlogix Corp.
|
Jul 31, 2019 12:09PM
|